An original stem cell study provides insight into Klinefelter syndrome.

Published Date: 05 Apr 2023

Scientists have conducted a first-of-its-kind study in a collaboration between King Abdullah University of Science and Technology (KAUST), King Abdulaziz University, Jeddah (KAU), and King Abdulaziz University Hospital, Jeddah (KAUH).

Read Full News

Latest News

Can Gut Bacterium Supplement Lead to Less Weight Regain?

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Stress, BMI Linked to Earlier Puberty in Girls

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

As GLP-1 Uptake Rises, Metabolic Surgery Rates Decline

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than 140% during the same period.

Did Hyperglycemia Affect Inavolisib-Efficacy in BC Patients?

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with numerically better outcomes among patients who develop the metabolic side effect.

Patients Over 65 With Obesity Respond Well to Semaglutide

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in adults aged 65 years or older.

How Bariatric Surgery Shapes IBD Risk Over Time in Obesity

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Todays Updates

All-Oral Treatment Combo for AML Earns FDA Nod

The combo, decitabine and cedazuridine tablets plus venetoclax, was approved for adults aged 75 and older and adults with comorbidities that preclude intensive induction chemotherapy.

Latest News

Daily supplementation with pasteurized Akkermansia muciniphila MucT after weight loss leads to less weight regain than placebo in adults with overweight or obesity.

Higher levels of non-estrogen hormones, along with stress and elevated BMI, are linked to earlier breast development in girls.

Metabolic bariatric surgery use declined by 34.1% from 2022 through 2024, whereas GLP-1 prescriptions increased by more than 140% during the same period.

Exploratory data show inavolisib benefits persist regardless of hyperglycemia in PIK3CA-mutated breast cancer, with numerically better outcomes among patients who develop the metabolic side effect.

In a pooled analysis of the STEP trials, semaglutide produced substantial weight loss and cardiometabolic improvements in adults aged 65 years or older.

In patients with severe obesity, metabolic and bariatric surgery was linked to a lower risk for inflammatory bowel disease within 3 years but a higher risk over longer follow-up.

News All Time

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Bridging Specialties to Manage Hyperglycemia in Breast Cancer Patients Treated With PI3K/AKT Pathway Inhibitors

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

Recognizing the Multifactorial Barriers to Effective Weight Loss in Obesity

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

From Crisis to Control: Strategies to Address Recurrent Severe Hypoglycemia in Type 1 Diabetes

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Contraceptive Considerations in the Modern Era: Navigating Non-Oral Options and Evolving Clinical Complexities

Doctors Urge Women to Be Wary of Marketing Surge in Menopause Products

"It really pays to be very, very, very skeptical," says one expert

Many Older Patients Can Ditch Common Thyroid Drug, Study Suggests

Experts call for better guidance on levothyroxine initiation, deprescribing

GLP-1 Pill Showdown; $35 Insulin Cap Success; Preterm Births Tied to Plastics

News and commentary from the endocrinology world

Drug Manufacturer Coupon Use; Cholesterol Targets for Secondary Prevention

Also in TTHealthWatch: deprescribing levothyroxine

Call to Integrate Obesity Management With Surgery, GLP-1s Into Cancer Care

"Most effective therapies" underutilized, say authors, but oncologist cites lack of quality data

Further Doubt on Heart-Healthiness of Calcium Supplements

Recurrent cardiovascular events increased in a large cohort study

Are GLP-1 Drugs Linked to Erectile Dysfunction?

Real-world study in type 2 diabetes suggests possible association, but more research is needed

Meal Monotony for Weight Loss; Genes Explain GLP-1 Response; Menopause Drug Boom

News and commentary from the endocrinology world

New GLP-1 Side Effect? Highest-Burnout Specialties; Trump's Psychedelic Plan

Health news and commentary gathered by MedPage Today staff

FDA Takes Steps to Expand Testosterone for Men's Libido

Agency last year removed boxed warning about risks for heart attack and stroke

Mobile Intervention Helps Moms With Obesity Reduce Gestational Weight Gain

Intervention uses a smartphone app to promote healthy eating and increased activity

Study Warns of High-Risk Group for Fatal Liver Disease

Risky drinking and obesity "contribute synergistically" to rising rates of liver disease, death

Recommended News For You

A global study demonstrates that screening for lung cancer significantly raises the long-term survival rate.

Health researchers discuss Medicaid cancer screening trends, best practices

'Chemo brain' cognitive issues linked to poor lymphatic-system drainage

Providing essential cancer care to rural communities

Adjuvant Tx May Boost Survival in Bilateral Breast Cancer

FAPI PET/CT enhances the staging of recently discovered breast cancer, according to comparative analysis.

'Sleep ALL night' program helps children with leukemia sleep better during treatment

Recommended Articles For You

Prognostic Role of PLAU in Pan-Cancer and Neutrophil Infiltration in Bladder Cancer 

The Silent Signs: Uncovering Stomach Cancer Symptoms Before It's Too Late 

Revolutionizing Cancer Treatment with Darzalex: How an Innovative Drug is Transforming Lives 

Next-Gen Cancer Therapies: Radiopharmaceuticals, Immuno-Oncology, and Biologic Breakthroughs 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Children with cancer tumors lacking DNA repair may benefit from olaparib combined with ceralasertib.

2.

Eight Doctors Killed in Brazil's Horrifying Plane Crash

3.

According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.

4.

An inoperable locally advanced NSCLC trial dubbed "Practice Changing".

5.

When Healthcare Chatbots Fall Short of Human Connection

1.

Exploring the Pleomorphic Adenoma: A Unique and Varied Tumor

2.

Unveiling the Complexity of Multiple Myeloma Staging

3.

Unlocking the Mysteries of Synovial Sarcoma: A New Hope for Treatment

4.

The Mysterious World of Petechiae: Exploring Causes and Treatments

5.

Holistic Oncology: Advancing Survivorship, Nursing, and Innovative Cancer Care Models

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

2.

Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL

3.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V

5.

EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion


Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot